Peter Herrlich

A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells

Ursula Günthert, Martin Hofmann‐Apitius, W. Rudy et al. · Cell · 1991 · 1.7K citations

Life Sciences, Cell Biology, Molecular Biology +14

Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone

Carsten Jonat, Hans J. Rahmsdorf, Kun-Koo Park et al. · Cell · 1990 · 1.6K citations

Life Sciences, Immunology, Oncology +12

A splice variant of CD44 expressed in the apical ectodermal ridge presents fibroblast growth factors to limb mesenchyme and is required for limb outgrowth

Larry S. Sherman, Derek A. Wainwright, Helmut Ponta et al. · Genes & Development · 1998 · 164 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +17

Ligand-independent activation of platelet-derived growth factor receptor is a necessary intermediate in lysophosphatidic, acid-stimulated mitogenic activity in L cells

Andreas Herrlich, Henrik Daub, Axel Knebel et al. · Proceedings of the National Academy of Sciences · 1998 · 157 citations

Life Sciences, Biochemistry, Cell Biology +17

Synthesis and biological evaluation of aeroplysinin analogues: a new class of receptor tyrosine kinase inhibitors

Klaus Hinterding, Axel Knebel, Peter Herrlich et al. · Bioorganic & Medicinal Chemistry · 1998 · 48 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13